Biodegradable composites

• US 20040054372A1
• Filed: 07/24/2003
• Published: 03/18/2004
• Est. Priority Date: 08/19/1997
• Status: Abandoned Application

• Current Assignee: University of Nottingham
• Original Assignee: BTG International Limited (Boston Scientific Corporation)
• Inventors: Corden, Thomas Joseph, Downes, Sandra, Jones, Ivor Arthur, Fisher, Sheila Eunice, Rudd, Christopher Douglas
• Application Number:
  US10/625,524
• Publication Number:
  US 20040054372A1
• Time in Patent Office: Days
• US Class Current: 606/77
• CPC Class Codes: A61L 27/44 having a macromolecular matrix
• CPC Class Codes: A61L 27/48 with macromolecular fillers
• CPC Class Codes: A61L 27/58 Materials at least partially resorbable by the body
• CPC Class Codes: B29C 2033/3871 the models being organic material, e.g. living or dead bodies or parts thereof
• CPC Class Codes: B29C 33/3892 Preparation of the model, e.g. by assembling parts
• CPC Class Codes: B29C 70/48 and impregnating the reinforcements in the closed mould, e.g. resin transfer moulding [RTM] , e.g. by vacuum
• CPC Class Codes: B29K 2995/0059 Degradable
• CPC Class Codes: B29L 2031/7532 Artificial members, protheses

Abstract

A fully biodegradable fibre reinforced composite adapted for use as a medical implant which is shaped and processed by means of a resin reaction injection transfer molding process adapted for predetermining shape, physical properties and degradation profile, shaped preform and/or composition for preparation of the shaped composite, process for the production of the shaped composite comprising obtaining a shaped preform and impregnating with resin with simultaneous processing thereof, shaped composite comprising thermoplastic matrix and fibres adapted for use as a medical implant, characterised by a differential degradation of matrix with respect to fibres adapted to degrade via an intermediate shaped structure comprising residual porous matrix or residual fibre form respectively and selection of composite is made for primary growth of a preferred cell type, throughout voids created by degraded matrix or fibre respectively, according to the desired healing or reconstruction locus, the shaped composites for use as an implant in surgical reconstruction, preferably for use in reconstructive surgery of bone or in reconstructive surgery of cartilage and/or meniscus selected from cranial, maxillofacial and orthopaedic surgery for the purpose of fixation, augmentation and filling in of defects, and method for the production of a shaped product comprising preparation of set sizes, shapes and configurations, eg plates, screws, rivets and other fixation devices according to a 3 dimensional template wherein the template is obtained by means of preparing a 3 dimensional image of a selected feature or area for implant, generating a mold as hereinbefore defined, selecting fibre and matrix for preparation of a composite, preparing a fibre preform by introducing fibre into the mould in an effective amount and arrangement, injecting matrix and catalyst and processing thereof with subsequent removal of the mold.

Claims

1. A biodegradable fibre-reinforced shaped composite suitable for use as a medical implant which is obtainable by a resin, (co)monomer and/or oligomer reaction injection transfer molding process comprising:

providing a shaped fibre preform comprising a presentation of reinforcing fibres in a regular, irregular or profiled fibre distribution in a tool or mould;

injecting into said preform in said tool or mould a composition comprising (co)monomers and/or oligomers and/or resin of a biodegradable thermoplastic polymer matrix in such a manner as to retain said distribution, orientation and/or fraction, of fibres and composite shape; and

(part) polymerising the composition in the mould or tool

wherein the composite comprises long fibres (which are up to 10² times greater in length than diameter) or long continuous fibres (which are 10²-10⁴ times greater in length than diameter).

2. Biodegradable fibre-reinforced shaped composite (according to claim 1) suitable for use as a medical implant comprising matrix and (long or long continuous) fibres wherein the matrix and fibres display differential rates of biodegradation as a function of the nature of material or molecular weight thereof such that in use the mat and/or fibre biodegrade via an intermediate comprising residual porous matrix or residual fibre form respectively providing voids suitable for primary growth of cells or providing a residual scaffold for attachment and growth of cells.

3. Biodegradable fibre-reinforced shaped composite according to claim 1 or 2 wherein the matrix and fibres comprise a combination of materials whereby a differential degradation rate is exhibited both within and between the matrix and/or fibre.

4. Biodegradable fibre-reinforced shaped composite according to claim 3 wherein the matrix is selected from polymers and copolymers of aliphatic polyesters, preferably poly-ε

-caprolactone.

5. Biodegradable fibre-reinforced shaped composite according to any of claims 1 to 4 wherein the fibre reinforcement is selected from ceramics such as beta-tricalcium phosphate and phosphate free calcium aluminium (Ca—

Al), bioglasses such as the glass form of calcium phosphate, calcium metaphosphate (CMP) and calcium sodium metaphosphate (CSM), mixtures of silica, sodium oxide, calcium oxide and phosphorus pentoxide, and polymeric materials as defined in claim 4.

6. Process for the producing a biodegradable fibre-reinforced shaped composite as hereinbefore defined in any of claims 1 to 5 comprising providing

a shaped fibre preform comprising a presentation of reinforcing fibres in a regular, irregular or profiled fibre distribution in a tool or mould;

injecting into said preform within said tool or mould a composition comprising (co)monomers and/or oligomers and/or resin of a biodegradable thermoplastic polymer matrix in such a manner as to retain said distribution, orientation and/or fraction, of fibres and composite shape; and

(part) polymerising the composition in the mould or tool,

characterised in that fibres are long fibres which are up to 10² times greater in length than diameter or long continuous fibres which are 10²-10⁴ times greater in length than diameter.

7. Biodegradable fibre-reinforced shaped composite as defined in any of claims 1 to 6 which is coated with or associated with or has embedded therein or is impregnated with a selected population of host and/or compatible donor cells, preferably bone derived and/or cartilage derived and/or collagen derived.

8. Biodegradable composite according to claim 7 comprising primary growth cells selected from bone, cartilage and tissue cells suitable for providing a supporting structure of live bone or cartilage or a live vascular structure within the partially biodegraded composite, adapted for further growth of remaining cells types for total integration as a functioning live system.

9. Biodegradable composite according to any of claims 7 and 8 suitable as a surgical implant for reconstruction of bone or cartilage or of soft tissue, muscle characterised by primary degradation rate of the matrix or of the fibre respectively.

10. Use of a composite according to any of claims 1 to 9 for in vivo tissue production by means of impregnation with cells, inductive proteins and therapeutic substances, wherein the composite is then suitable for introduction into a living host, biodegradation and cell growth and subsequent harvesting the composite in partial or substantially impregnated and/or biodegraded state and reimplanting in a locus for reconstructive surgery.

11. Method for the production of a shaped product comprising providing a mould or tool comprising a 3 dimensional template of a 3 dimensional image of a selected feature or area for implant, providing a fibre preform by introducing fibre into the mould or tool in an effective amount and arrangement, injecting (co)monomers and/or oligomers and/or resin and catalyst and/or initiator and polymerising with subsequent removal of the mould or tool from the shaped product suitable for introduction into a recipient by appropriate means.

12. Method according to claim 11 wherein the mould or tool is provided by

(i) medical imaging of a selected feature or area of a patient complementary to or symmetrical with a feature or area to be replaced and/or restructured to obtain data comprising a plurality of co-ordinates defining a three dimensional image:

(ii) passing data collected from medical imaging to a translating system which interprets said data and generates information for transferring said data to a rapid prototyping system suitable for generating a mould or tool;

and wherein fibre comprises long or continuous fibres providing directional reinforcement.